Professor Chung Ji LIU
1. Department of Oral and Maxillofacial Surgery, MacKay Memorial Hospital, Taipei, Taiwan.
2. Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.
3. Institute of Oral Biology, School of Dentistry, National Yang-Ming Chiao Tung University, Taipei, Taiwan,
Education:
1983-1989 DDS, School of Dentistry, National Yang Ming University
2000-2002 Master, School of Dentistry, National Yang Ming University
Experience:
1991-1995 Resident, Veteran General Hospital, Taipei, Taiwan
1995-2008 Attending Physician, MacKay Memorial Hospital, Taipei, Taiwan
2008-2014 Chief, Department of Oral and Maxillofacial Surgery, MacKay Memorial Hospital, Taipei, Taiwan
2014- Chief, Department of Stomatology, Mackay Memorial Hospital,
Taiwan
2010- Professor, National Yang Ming University
Published articles (2017-2022)
1. Hsuan Yu Chen, Li-Han Lin, Chung Ji Liu (2022, May). Risk factors for
reconstruction plate exposure after surgery in oral cancer patients. A
retrospective cohort study. Clinical Oral Investigations, 26, pages 4127–4136.
2. HF Tu, KW Chang, SC Lin, WW Hung, SH Ji, HL Wu, CJ Liu (2022, Apr).
Aberrant miR-10b, miR-372, and miR-375 expression in the cytobrushed
samples from oral potentially malignant disorders. J Dent Sci, Volume 17, Issue
2, April 2022, Pages 688-695.
3. HF Tu, LH Lin, HW Cheng, KW Chang, CJ Liu (2022, Apr). Exploiting salivary
miR-375 as a clinical biomarker of oral potentially malignant disorder . J Dent
Sci, Volume 17, Issue 2, April 2022, Pages 659-665.
4. Li-Han Lin, Chung-Hsien Chou, Hui-Wen Cheng, Kuo-Wei Chang, Chung-Ji Liu
(2021, Nov). Precise Identification of Recurrent Somatic Mutations in Oral
Cancer Through Whole-Exome Sequencing Using Multiple Mutation Calling
Pipelines. Front Oncol, 2021 Nov 29;11:741626. doi:10.3389/fonc.2021.741626.
5. Lin LH, Cheng HW, Liu CJ. (2021, Jul). Droplet digital polymerase chain
reaction for detection and quantification of cell-free DNA TP53 target somatic
mutations in oral cancer. Cancer Biomark, 2021 Jul 30. doi: 10.3233/CBM-
210275.
6. Lin SC, Liu CJ, Ji SH, Hung WW, Liu YC, Chang SR, Tu HF, Chang KW. (2021,
Jul). The upregulation of oncogenic miRNAs in swabbed samples obtained from
oral premalignant and malignant lesions. Clin Oral Investig, doi:
10.1007/s00784-021-04108-y. .
7. Huang TH, Kuo PJ, Liu CJ. (2021, May). Comparison of surgical outcomes
between primary plate and fibular flap transfer for reconstruction of segmental
mandibular defects. . Microsurgery, May;41(4):327-334.
8. CY Cheng, FJ Sun, CJ Liu (2020, May). The influence of cervical lymph node
number of neck dissection on the prognosis of the early oral cancer patients.
Journal of Dental Sciences, https://doi.org/10.1016/j.jds.2020.06.002.
9. Li WC, Huang CH, Hsieh YT, Chen TY, Cheng LH, Chen CY, Liu CJ, Chen
HM, Huang CL, Lo JF, Chang KW. (2020, Mar). Regulatory Role of Hexokinase
2 in Modulating Head and Neck Tumorigenesis.. Front Oncol. , 10:176. doi:
10.3389/fonc.2020.00176. .
10. Lin LH, Lin JS, Yang CC, Cheng HW, Chang KW, Liu CJ. (2020, Mar).
Overexpression of Platelet-Derived Growth Factor and Its Receptor Are
Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell
Carcinoma.. Int J Mol Sci. , 29;21(7):2360. doi: 10.3390/ijms21072360..
11. Yeh LY, Yang CC, Wu HL, Kao SY, Liu CJ, Chen YF, Lin SC, Chang KW.
(2020, Jan). The miR-372-ZBTB7A Oncogenic Axis Suppresses TRAIL-R2
Associated Drug Sensitivity in Oral Carcinoma.. Front Oncol., 31;10:47. doi:
10.3389/fonc.2020.00047.
12. Lin LH, Chang KW, Cheng HW, Liu CJ. (2019, Dec). SMAD4 Somatic
Mutations in Head and Neck Carcinoma Are Associated With Tumor
Progression.. Front Oncol. , 6;9:1379. doi: 10.3389/fonc.2019.01379. .
13. Pidugu VK, Pidugu HB, Wu MM, Liu CJ, Lee TC. (2019, Dec). Emerging
Functions of Human IFIT Proteins in Cancer.. Front Mol Biosci, 19;6:148. doi:
10.3389/fmolb.2019.00148..
14. Kao YY, Chou CH, Yeh LY, Chen YF, Chang KW, Liu CJ, Fan Chiang CY, Lin
SC. (2019, Aug). MicroRNA miR-31 targets SIRT3 to disrupt mitochondrial
activity and increase oxidative stress in oral carcinoma.. Cancer Lett. , 456:40-
48.
15. Chen TY, Hsieh YT, Huang JM, Liu CJ, Chuang LT, Huang PC, Kuo TY, Chia
HY, Chou CY, Chang CW, Chen YF, Chen HM, Lo JF, Li WC. (2019, Jul).
Determination of Pyruvate Metabolic Fates Modulates Head and Neck
Tumorigenesis.. Neoplasia. , 21(7):641-652..
16. Chen YF, Liu CJ, Lin LH, Chou CH, Yeh LY, Lin SC, Chang KW. (2019, May).
Establishing of mouse oral carcinoma cell lines derived from transgenic mice
and their use as syngeneic tumorigenesis models. BMC Cancer. . doi:
10.1186/s12885-019-5486-, 29;19(1):281.
17. Tsou HH, Hu CH, Liu JH, Liu CJ, Lee CH, Liu TY, Wang HT. (2019, May).
Acrolein Is Involved in the Synergistic Potential of Cigarette Smoking- and Betel
Quid Chewing-Related Human Oral Cancer. Cancer Epidemiol Biomarkers
Prev., 28(5):954-962. DOI: 10.1158/1055-9965.EPI-18-1033..
18. Liu CJ, Chen JH, Hsia SM, Liao CC, Chang HW, Shieh TM, Shih YH. (2019,
Apr). Salivary LDOC1 is a gender-difference biomarker of oral squamous cell
carcinoma.. PeerJ., 9;7:e6732.
19. Pidugu VK, Wu MM, Yen AH, Pidugu HB, Chang KW, Liu CJ, Lee TC. (2019,
Apr). IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and
contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling..
Oncogene, 38(17):3232-3247. doi: 10.1038/s41388-018-0662-9.
20. Yi-Fen Chen, Yun-Yen Wei, Cheng-Chieh Yang, Chung-Ji Liu, Li-Yin Yeh,
Chung-Hsien Chou, Kuo-Wei Chang, Shu-Chun Lin (2019, Apr). miR-125b
suppresses oral oncogenicity by targeting the anti-oxidative gene PRXL2A.
Redox Biol, 2019 Apr;22:101140.
21. Peng SY, Tu HF, Yang CC, Wu CH, Liu CJ, Chang KW, Lin SC. (2018, Dec).
miR-134 targets PDCD7 to reduce E-cadherin expression and enhance oral
cancer progression. Int J Cancer., 143(11):2892-2904.
22. Shu-Chun Lin, Li-Han Lin, Ssu-Yu Yu, Shou-Yen Kao, Kuo-Wei Chang, Hui-Wen
Cheng, Chung-Ji Liu (2018, Dec). FAT1 somatic mutations in head and neck
carcinoma are associated with tumor progression and survival. Carcinogenesis,
13;39(11):1320-1330. doi: 10.1093/carcin/bgy107.
23. Li-Han Lin, Kuo-Wei Chang , Shou-Yen Kao, Hui-Wen Cheng, Chung-Ji Liu
(2018, Nov). Increased Plasma Circulating Cell-Free DNA Could Be a Potential
Marker for Oral Cancer. International J molecular sciences, Oct 24;19(11). pii:
E3303.
24. JS.Lin, FJ Sun.Y.Lin KW Chang , CC.Yang CJ Liu (2018, Oct).
Clinicopathological and prognostic significance of preoperative serum epidermal
growth factor levels in patients with oral squamous cell carcinoma. International
Journal of Oral and Maxillofacial Surgery, 47(10) 1236-1242.
25. Chou CH, Tu HF, Kao SY, Chiang CF, Liu CJ, Chang KW, Lin SC. (2018, Apr).
Targeting of miR-31/96/182 to the Numb gene during head and neck
oncogenesis.. Head Neck. , 40(4):808-817.
26. Liu CJ, Lin JS, Cheng HW, Hsu YH, Cheng CY, Lin SC. Plasma miR-187* is a
potential biomarker for oral carcinoma (2017, May). Plasma miR-187* is a
potential biomarker for oral carcinoma. Clin Oral Invest, 21(4):1131-1138.
27. Su NW, Wu SH, Chi CW, Liu CJ, Tsai TH, Chen YJ. (2017, Apr). Metronomic
Cordycepin Therapy Prolongs Survival of Oral Cancer-Bearing Mice and
Inhibits Epithelial-Mesenchymal Transition. Molecules., 13;22(4):629. doi:
10.3390/molecules22040629..
